Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

adverse events

  • You have access
    Improvement of Medication Guidance Sheet for Total Body Irradiation/Cyclophosphamide Followed by Allogeneic Hematopoietic Stem Cell Transplantation Based on Real Monitoring Data
    MAYAKO UCHIDA, SHIGERU ISHIDA, ERIKA MOCHIZUKI, NANA OZAWA, HIROKO YONEMITSU, HIDEKI OCHIAI, HANAE NAKAMURA, TAKEHIRO KAWASHIRI, KOJI KATO, NOBUAKI EGASHIRA, KOICHI AKASHI and ICHIRO IEIRI
    Anticancer Research September 2023, 43 (9) 4067-4075; DOI: https://doi.org/10.21873/anticanres.16596
  • You have access
    Development of Real-world Data-based Medication Instruction Sheet for Acute Myeloid Leukemia Patients Receiving High-dose Cytarabine Consolidation Therapy
    MAYAKO UCHIDA, SHIGERU ISHIDA, ERIKA MOCHIZUKI, NANA OZAWA, HIROKO YONEMITSU, HIDEKI OCHIAI, HANAE NAKAMURA, TAKEHIRO KAWASHIRI, KOJI KATO, NOBUAKI EGASHIRA, KOICHI AKASHI and ICHIRO IEIRI
    Anticancer Research July 2023, 43 (7) 3321-3329; DOI: https://doi.org/10.21873/anticanres.16508
  • Open Access
    Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment
    SATOSHI FUKUDA, YUSUKE NIISATO, MIKI TSUJI, SOMA FUKUDA, YUYA HAGIWARA, TSUBASA ONODA, HIROSUMI SUZUKI, YOSHITAKA TANGE, TAKESHI YAMADA, YOSHIYUKI YAMAMOTO and TOSHIKAZU MORIWAKI
    Anticancer Research May 2023, 43 (5) 2085-2090; DOI: https://doi.org/10.21873/anticanres.16369
  • You have access
    Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
    SOICHI TAKEDA, TADASHI NAMISAKI, YUKI TSUJI, YUKI FUJIMOTO, KOJI MURATA, MASAHIDE ENOMOTO, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, KOH KITAGAWA, HIROAKI TAKAYA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI
    Anticancer Research November 2022, 42 (11) 5465-5473; DOI: https://doi.org/10.21873/anticanres.16051
  • You have access
    Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
    YUKI FUJIMOTO, TADASHI NAMISAKI, SOICHI TAKEDA, KOJI MURATA, MASAHIDE ENOMOTO, HIROAKI TAKAYA, YUKI TSUJI, YUKIHISA FUJINAGA, YASUHIKO SAWADA, NORIHISA NISHIMURA, KOH KITAGAWA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, KEI MORIYA, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI
    Anticancer Research October 2022, 42 (10) 4895-4905; DOI: https://doi.org/10.21873/anticanres.15995
  • Open Access
    Counteracting Side-effects of Photodynamic Therapy for Actinic Keratoses
    HANS CHRISTIAN WULF and IDA M. HEERFORDT
    Anticancer Research October 2022, 42 (10) 5017-5020; DOI: https://doi.org/10.21873/anticanres.16009
  • Open Access
    Adverse Events in Placebo Arms of Cancer Trials
    JOHANNES E. WOLFF, BIRTE J. WOLFF, MARCEAL M. THIELEN and HOLGER HAUCH
    Anticancer Research June 2022, 42 (6) 2805-2812; DOI: https://doi.org/10.21873/anticanres.15761
  • You have access
    Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin’s Lymphoma Receiving ESHAP±R Therapy
    MAYAKO UCHIDA, SAEKO MURATA, HANAE MORIKAWA, HIROKO YONEMITSU, SHIGERU ISHIDA, KIMITAKA SUETSUGU, TOSHIKAZU TSUJI, HIROYUKI WATANABE, TAKEHIRO KAWASHIRI, KOJI KATO, KEIKO HOSOHATA, TOSHIHIRO MIYAMOTO, NOBUAKI EGASHIRA, TSUTOMU NAKAMURA, KOICHI AKASHI and ICHIRO IEIRI
    Anticancer Research April 2022, 42 (4) 2053-2060; DOI: https://doi.org/10.21873/anticanres.15686
  • You have access
    The Role of Community Pharmacists in Addressing Medication-related Issues for Breast Cancer Patients Receiving Adjuvant Endocrine Therapy
    KINAN MOKBEL and KEFAH MOKBEL
    Anticancer Research February 2022, 42 (2) 661-666; DOI: https://doi.org/10.21873/anticanres.15524
  • You have access
    Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
    NAOTAKA SHIMOZATO, TADASHI NAMISAKI, AKIHIRO OKANO, MASAYA OHANA, DAISUKE KINOSHITA, TOSHIHIKO KAWASAKI, YOSUKE AIHARA, TOSHIYA NAKATANI, HIROKI KINOSHITA, TATSUICHI ANN, KO SAITO, MOTOYUKI YOSHIDA and HITOSHI YOSHIJI
    Anticancer Research January 2022, 42 (1) 173-183; DOI: https://doi.org/10.21873/anticanres.15471

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire